AbstractWe have systemically investigated unusual elution behaviors of an IgG4 (mAb A) in cation exchange chromatography (CEX). This mAb A exhibited two elution peaks under certain conditions when being purified by several strong CEX columns. When either of the two peaks was isolated and re-injected on the same column, the similar pattern was observed again during elution. The protein distribution between the two peaks could be altered by NaCl concentration in the feed, or NaCl concentration in wash buffer, or elution pH, suggesting two pH-associated strong-and-weak binding configurations. The protein distributions under different pH values showed good correlation with protonated/un-protonated fractions of a histidine residue. These results...
In the commercial manufacturing of monoclonal antibodies (mAbs), several of the downstream operation...
Heterogeneity of therapeutic Monoclonal antibody (mAb) drugs are due to protein variants generated d...
A vital part of biopharmaceutical research is decision making around which lead candidate should be ...
Cation exchange chromatography, as part of the monoclonal antibody purification train, is known as a...
AbstractSome monoclonal antibodies (mAbs) are reported to display concentration-dependent reversible...
Aggregation of proteins is a critical quality attribute and a major concern during the purification ...
Charge variant analysis (CVA) of monoclonal antibodies (mAbs) using cation exchange chromatography i...
AbstractProtein A chromatography is a near-ubiquitous method of mAb capture in bioprocesses. The use...
Cation exchange chromatography (CEX) is a well established strategy for the characterization of mono...
Monoclonal antibody drug conjugate (ADCs) have received much attention as pharmaceutical agents for ...
Cation exchange chromatography has been routinely used for the quantification of monoclonal antibody...
The purification of a biopharmaceutical is not a simple task, and to ensure the quality and consiste...
tCation exchange chromatography (CEX) of therapeutic monoclonal antibodies is generally performedwit...
Therapeutic monoclonal antibodies (mAbs) represent a very important class of the current biopharmace...
Recombinant monoclonal antibody charge heterogeneity has been commonly observed as multiple bands or...
In the commercial manufacturing of monoclonal antibodies (mAbs), several of the downstream operation...
Heterogeneity of therapeutic Monoclonal antibody (mAb) drugs are due to protein variants generated d...
A vital part of biopharmaceutical research is decision making around which lead candidate should be ...
Cation exchange chromatography, as part of the monoclonal antibody purification train, is known as a...
AbstractSome monoclonal antibodies (mAbs) are reported to display concentration-dependent reversible...
Aggregation of proteins is a critical quality attribute and a major concern during the purification ...
Charge variant analysis (CVA) of monoclonal antibodies (mAbs) using cation exchange chromatography i...
AbstractProtein A chromatography is a near-ubiquitous method of mAb capture in bioprocesses. The use...
Cation exchange chromatography (CEX) is a well established strategy for the characterization of mono...
Monoclonal antibody drug conjugate (ADCs) have received much attention as pharmaceutical agents for ...
Cation exchange chromatography has been routinely used for the quantification of monoclonal antibody...
The purification of a biopharmaceutical is not a simple task, and to ensure the quality and consiste...
tCation exchange chromatography (CEX) of therapeutic monoclonal antibodies is generally performedwit...
Therapeutic monoclonal antibodies (mAbs) represent a very important class of the current biopharmace...
Recombinant monoclonal antibody charge heterogeneity has been commonly observed as multiple bands or...
In the commercial manufacturing of monoclonal antibodies (mAbs), several of the downstream operation...
Heterogeneity of therapeutic Monoclonal antibody (mAb) drugs are due to protein variants generated d...
A vital part of biopharmaceutical research is decision making around which lead candidate should be ...